TNF and inflammatory bowel disease: Although TNF-α antagonists are extensively used in IBD management as they are known to reduce the inflammatory burden and aid mucosal healing in some; however, data indicating its potential cardioprotective effect on decreasing the risk of CVD in IBD patients is scarce.